Opko Health: Katherine Stueland

Opko Health announced Katherine Stueland as its subsidiary GeneDx's president and CEO. She was previously chief commercial officer at Invitae and has served as VP of communications and investor relations at Dendreon and associate director at TAP Pharmaceuticals, a joint venture between Abbott and Takeda.